Skip to main content
. 2019 Apr 17;13:561–576. doi: 10.2147/PPA.S187907
1 Glucagon-Like Peptide-1 Receptor/(2091)
2 Glucagon-Like Peptide 1/(6642)
3 Glucagon-Like Peptides/(1313)
4 Receptors, Glucagon/(2281)
5 ((glucagon-like peptide-1 or glucagon-like peptide1 or glp-1 or glp1) adj5 (agonist$1 or analogue$1 or stimulating agent$1)).ti,ab,kf,rn,nm. (3626)
6 ((glucagon-like peptide-1r or glucagon-like peptide1r or glp-1r or glp1r) adj5 (agonist$1 or analogue$1 or stimulating agent$1)). ti,ab,kf,rn,nm. (426)
7 (glp-1-ra or glp1-ra or glp-1ra or glp1ra or glp-1-ras or glp1-ras or glp-1ras or glp1ras).ti,ab,kf,rn,nm. (394)
8 incretin mimetic$1.ti,ab,kf,rn,nm. (324)
9 exenatide$.ti,ab,kf,rn,nm. (2693)
10 (ac-2993$2 or ac-2993a$2 or ac002993$2 or ac-002993$2 or ac2993$2 or ac2993a$2 or ac-2993lar$2 or bydureon$ or byetta$ or da-3091$2 or ex4 peptide$2 or exendin$2 or itca-650$2 or ly-2148568$2 or ly2148568$2).ti,ab,kf,rn,nm. (1801)
11 (141732-76-5 or 141758-74-9 or 9p1872d4ol).ti,ab,kf,rn,nm. (2048)
12 Liraglutide/(1130)
13 liraglutide$.ti,ab,kf,rn,nm. (1987)
14 (ideglira$2 or nn-2211$2 or nn-9068$2 or nn2211$2 or nn9068$2 or nn9924$2 or nn-9924$2 or nnc-90-1170$2 or nnc90-1170$2 or saxenda$2 or victoza$2 or xultophy$2).ti,ab,kf,rn,nm. (152)
15 (204656-20-2 or 839I73S42A).ti,ab,kf,rn,nm. (1130)
16 lixisenatide$.ti,ab,kf,rn,nm. (296)
17 (adlyxin$2 or aqve-10010$2 or aqve10010$2 or ave-0010$2 or ave0010$2 or ave-010$2 or ave010$2 or hoe 901$2 or hoe901$2 or iglarlixi$2 or lantus$2 or lixilan$2 or lyxumia$2 or soliqua$2 or suliqua$2 or zp-10$2 or zp10$2).ti,ab,kf,rn,nm. (243)
18 (320367-13-3 or 74O62BB01U).ti,ab,kf,rn,nm. (118)
19 albiglutide$.ti,ab,kf,rn,nm. (140)
20 (albugon$2 or albumin glp 1 or albumin glucagon like peptide 1 or eperzan$2 or glp 1 albumin or glucagon like peptide 1 albumin or gsk-716155$2 or gsk716155$2 or gsk-716155a$2 or gsk716155a$2 or naliglutide$2 or syncria$2 or tanzeum$2).ti,ab,kf,rn,nm. (16)
21 (782500-75-8 or 5E7U48495E).ti,ab,kf,rn,nm. (66)
22 dulaglutide$.ti,ab,kf,rn,nm. (184)
23 (ly2189265$2 or ly-2189265$2 or trulicity$2).ti,ab,kf,rn,nm. (21)
24 (923950-08-7 or WTT295HSY5).ti,ab,kf,rn,nm. (90)
25 semaglutide$.ti,ab,kf,rn,nm. (120)
26 (nn9535$2 or nn-9535$2 or nnc-0113-0217$2 or ozempic$2).ti,ab,kf,rn,nm. (4)
27 (910463-68-2 or 53AXN4NNHX).ti,ab,kf,rn,nm. (19)
28 or/1-27 (12783)
29 Patient Preference/(5997)
30 prefer$.ti,ab,kf. (391979)
31 Choice Behavior/(28476)
32 discrete choice$.ti,ab,kf. (1454)
33 choice experiment$1.ti,ab,kf. (2127)
34 (dce or dces).ti,ab,kf. (4638)
35 discrete rank$.ti,ab,kf. (3)
36 standard gamble$.ti,ab,kf. (785)
37 sg.ti,ab,kf. (8212)
38 time trade off.ti,ab,kf. (1015)
39 tto.ti,ab,kf. (882)
40 willing$.ti,ab,kf. (33298)
41 (wtp or wta or wtt).ti,ab,kf. (1710)
42 conjoint.ti,ab,kf. (2374)
43 contingent valuation$1.ti,ab,kf. (606)
44 (multi-criteria decision$ or multiple-criteria decision$).ti,ab,kf. (562)
45 (mcda or mcdm).ti,ab,kf. (509)
46 (maxdiff or max diff).ti,ab,kf. (18)
47 maximum differential$.ti,ab,kf. (36)
48 ((best$ or worst) adj2 (scaling or scale or scales)).ti,ab,kf. (670)
49 (utility or utilities or hsuv or hsuvs).ti,ab,kf. (169818)
50 or/29-49 (622370)
51 28 and 50 (426)
52 exp animals/not humans/(4430952)
53 51 not 52 (310)
54 limit 53 to (english language and yr=“2005-Current”) (286)
55 remove duplicates from 54 (284)